MDB Capital (NASDAQ:MDBH) Posts Earnings Results

MDB Capital (NASDAQ:MDBHGet Free Report) issued its quarterly earnings data on Thursday. The company reported $999.00 earnings per share for the quarter, reports.

MDB Capital Trading Up 11.2%

MDBH traded up $0.36 during midday trading on Friday, reaching $3.57. The company’s stock had a trading volume of 4,891 shares, compared to its average volume of 3,444. The company has a fifty day simple moving average of $3.32 and a 200 day simple moving average of $3.38. The stock has a market cap of $36.77 million, a P/E ratio of -1.68 and a beta of 1.24. MDB Capital has a twelve month low of $2.75 and a twelve month high of $5.50.

Institutional Investors Weigh In On MDB Capital

Several hedge funds have recently modified their holdings of the business. Raymond James Financial Inc. acquired a new position in MDB Capital during the 2nd quarter valued at $27,000. DRW Securities LLC bought a new position in MDB Capital during the fourth quarter valued at about $40,000. Finally, Citadel Advisors LLC bought a new position in MDB Capital during the third quarter valued at about $43,000. 0.35% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of MDB Capital in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, MDB Capital presently has a consensus rating of “Sell”.

Read Our Latest Stock Analysis on MDB Capital

About MDB Capital

(Get Free Report)

MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business.

Featured Stories

Earnings History for MDB Capital (NASDAQ:MDBH)

Receive News & Ratings for MDB Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDB Capital and related companies with MarketBeat.com's FREE daily email newsletter.